|
Introduction
|
Welcome to the Spotlight Feature sponsor, MedMining, which draws its data from Geisinger Health System. Learn more about their deep and broad dataset in the Spotlight Feature at the right. Contact us immediately if you would like to be featured in the Spotlight in future newsletters. We are booked through October, so reserve early! Our Job of the Week is Director, Health Economics & Outcomes Research at a
well-respected pharma company located in New Jersey. This time-sensitive
position will offer excellent benefits and the right individual will have an
opportunity to shine and demonstrate leadership in the areas of strategy,
design, implementation and delivery of health economics and outcomes studies.
Make sure you apply today. Our Conference of the Week is DIA Biosimilars Workshop, September 28, 2009, 9 AM- 5 PM, London, UK. This conference will provide insight into guidelines and approval of biosimilars in the EU, USA and Japanese markets as well as providing lessons learned in Industry. Make sure you attend this to help your organization develop and market effectively. DIA is registering participants for their Health Technology Assessment Forum, in Paris, France, November 25-26, 2009. For a solid overview of this area, make sure you attend. Just click on the logo under the "Our Sponsors" section at the right, or click here. CBI is offering a 3-Part Webinar Series on Pricing which will give participants a better understanding of appropriate techniques and strategies. To learn more, click here. Part I: September 1, 1-2 PM EDT, "Pricing: What Pricing Techniques are Appropriate?" Part II: September 30, 1-2 PM EDT, "Segmentation: The Why and How" Part III: October 21, 1-2 PM EDT, "Global Pricing Issues- An Overview" Thank you to the over 300 people who have taken our 30 second survey. If you haven't taken it, won't you please do so? Health Economics.Com works hard to make the content of our newsletter relevant for you. Your responses are anonymous. Your participation will help us tailor future issues of the newsletter to your particular job and business. Did you miss a newsletter or want to re-read an issue? Don't worry. To view earlier newsletters, click here.
If your company, conference, survey, or HEOR department would like to be highlighted as the Spotlight Feature, contact us immediately. Hiring? Searching for a job? Contact us today. Make sure your HR and Marketing Depts. know about HealthEconomics.Com. |
| | |
| Recent News |
The Methods Guide for Comparative Effectiveness Reviews intends to
improve the transparency, consistency, and scientific rigor of this
work, which consists of systematic reviews of existing research on
effectiveness, comparative effectiveness, and comparative harm of
different health care interventions. The original chapters have been posted for review in the draft guide,
which intends to be a live document, revised according to public and
peer comment and ongoing evidence. Two new chapters have recently been
added:
- Principles for Developing Guidance for Comparing Medical Interventions
- Grading the Strength of a Body of Evidence when Comparing Medical Interventions
To see updates, click here.
Primer in AJHP by Schumock and Pickard: "Comparative Effectiveness Research: Relevance and Applications to Pharmacy" is a good basic overview.
GPs would get new incentives to treat diabetes under NICE proposals. Read more here.
Read Robert Reich's hard-hitting article in the Aug. 10 Salon.Com on "The White House deal with Big Pharma undermines democracy". See video of President Obama's weekly address on healthcare reform here.
The CBO says preventative care will raise healthcare costs, not lower them. Read more here. Critics say that all relevant preventative care was not factored in.
Four in 10 US Emergency Department Visits Billed to Public
Insurance (Medicare and Medicaid), based on HCUP Statistical Brief #77: Payers of Emergency Department Care, 2006.
HarvardBusiness.Org article provides excellent graphics and comparators re health reform, "How to Think Constructively About Healthcare".
Don't miss the recent NEJM issue devoted to health reform. I particularly like "Keeping the Patient in the Equation - Humanism and Health Care Reform" by Hartzband and Groopman.
Healthcare Reform Series: The French health care system. This site also gives access to earlier articles, including the British, German, Japanese, Canadian, and US systems.
ICD-10 Implementation Should Begin By January 18, 2010. View timeline here (From Healthcare Technology News).
AHRQ Announces Intent to Publish Grant and Contract Solicitations for Comparative Effectiveness Research (CER) Projects with Funds from
the American Recovery and Reinvestment Act (ARRA). ARRA funding will focus, initially, on 14 priority conditions
established by the Secretary of the Department of Health and Human
Services.
Funding Opportunity Announcements soliciting research grant
applications for CER will provide $148 million for evidence
generation.
This includes $100 million for the Clinical and Health
Outcomes Initiative in Comparative Effectiveness (CHOICE), a new,
coordinated, national effort to establish a series of prospective
pragmatic clinical comparative effectiveness studies that measure the
benefits treatments produce in routine clinical practice and will
include novel study designs focusing on real-world and
under-represented populations (children, elderly, racial and ethnic
minorities, and other understudied populations)
Also includes $48 million for
the establishment or enhancement of national patient registries that
can be used for researching the longitudinal effects of different
interventions and collecting data on under-represented populations.
Additional grant funding includes $29.5 million to support innovative
translation and dissemination grants for CER, as well as $20 million to
support training and career development in CER. Read more here.
Article on "Pharmaceutical Industry at Crossroads: Experts suggest innovate, collaborate or merge" has some interesting perspectives.
PharmExec.Com details innovative adherence programs developed by various companies in the article "A Hard Pill to Swallow" by
George Koroneos.
|
|
Hot Web Resources
|
Aug. 18, 2009; 1:30pm EST, 90 minutes Webinar "Disclosing Negative Results" gives you the tools you need to manage issues associated with negative (or less than desirable) results.
Institute for Clinical Systems Improvement (ICSI) has updated measures and guidelines for adult major depression, coronary artery disease, stroke, insulin-dependent diabetes, and others.
Entrepreneurs and innovators associated with the pharma/biotech industry offer their views on the future in this PharmaVoice publication, "The Entrepreneurs".
A must read: "Rethinking Randomized Clinical Trials for Comparative Effectiveness Research: The Need for Transformational Change" by Bryan Luce and others in August 4, 2009 issue of Annals of Internal Medicine.
Another venerable voice in our field, Dr. Jerry Avorn, weighs in on "Will Health-Care Reform Save Medical Innovation? An Interview With Dr. Jerry Avorn".
A new study funded by the National Pharmaceutical Council (NPC) shows that pharmacogenomics -- the field of scientific research focused on learning how genetic profiles predict the body's response to medicines - has the potential to lead to higher levels of research and development (R&D) investment and an increased pace of pharmaceutical innovation, offering substantial benefits for patients. Read article by Cook, et al. in PharmacoEconomics entitled "The Future Costs, Risks and Rewards of Drug Development: The Economics of Pharmacogenomics" (abstract free, article is paid access)
MEPS Statistical Brief gives great data on health insurance costs for families, individuals, employees, etc. The cost to insure a family of 4 in the US with an employer-sponsored health plan is $12,298 in 2008. Learn more here.
|
Education and Training
|
Joint Fellowship in Economics of Health, London. The Economic and Social Research Council, Medical Research Council, and National Institute for Health Research have recognized health economics as strategically important to the UK and are thus offering this joint early-career fellowship. The goal of the fellowship is to "undertake additional training and gain further research related skills, publish publications arising from the Fellow's PhD, and disseminate research findings and evidence their application to the research agenda in Economics of Health."
Closing date for the competition is September 25, 2009.
To learn more about funding and application submission, click here.
2-Day Course in Cambridge: WinBUGS in Economic Evaluations, September 23-24, 2009. Course taught by Dr. Chris Jackson (MRC Biostatistics Unit, Cambridge, UK) and Dr. Richard Nixon (Novartis, Basel, Switzerland). "This course is intended to provide an introduction to Bayesian analysis
and MCMC methods using WinBUGS, as applied to cost-effectiveness
analysis and typical models used in health-economic evaluations." With an emphasis on practical examples, no previous knowledge on WinBUGS assumed.
A new book by Dr. Diane Dewar, Essentials of Health Economics, is an excellent choice for a basic text or reference book. Learn more here.
A Brief History of "Evidence-Based Medicine" is available here.
"Modelling the monetary value of a QALY: a new approach based on UK data" is an excellent article by Mason, et. al. in Health Economics, August 2009.
HealthEconomics.Com offersFREE job postings for Post-Docs, Fellowships, Internships, Residencies, or Scholarship
Announcements. Email us the position
information. |
|
Ongoing Surveys
|
Are you located OUTSIDE the US? Can you give us just 30 seconds of your time to tell us a little about yourself in our short Demographic Survey? Your responses are anonymous. Your participation will help us tailor future issues of the newsletter to your particular job and business.
Thank you for your help on the survey!
To promote your survey to researchers, clinicical decision-makers, payers based in pharma/biotech, managed care, hospitals, universities, and government, contact HealthEconomics.Com.
|
Forums: Networking, Q&A, Ideas
|
Double Helix Consulting US, a division of London-based Double Helix
Development Group, today announced the relocation of its operations in Scarsdale, New York to
midtown Manhattan, enhancing the ability to efficiently and conveniently travel
to the offices of our customers and allow for recruiting talented individuals to the growing firm.
The service of ISPOR Board of
Directors 2009-2010 is greatly appreciated. They include 2009-2010 President, Michael Barry MD, PhD, President-elect Scott Ramsey MD, PhD,
Past President
Chris L. Pashos PhD, Directors Paul Kind,
Shelby Reed PhD, RPh,
Ansgar Hebborn PhD, Penny Mohr
MA, Zeba M. Khan RPh, PhD, Don Husereau
BScPharm, MSc, and Shanlian Hu MD, MSc, Treasurer Karen Rascati RPh, PhD, and ISPOR Founding Executive
Director Marilyn Dix Smith RPh, PhD. Let HealthEconomics.Com know if you have announcements about your company, products, or employees.
UC Berkeley has many courses starting soon in the areas of informatics, project management, various basic sciences, clinical research, and other areas. Visit the Forums/Education to learn more. First call for abstracts for ISPOR South Africa 2nd Annual Conference, North West University, Potchefstroom from 21st to 23rd September 2009. Abstracts due by 31 Aug, 2009 to Elize Wessels at info@isporsa.co.zaTwitter updates from AHRQ available here. Ulf Staginnus, of the HealthEconomics Blog, and a colleague will be running a workshop on Risk Sharing at ISPOR Paris, Fall 2009. Click here to register. Ulf has been deeply involved in studying this issue for quite a while, so I know it will be an informative workshop. Have you visited our Forums? Established to facilitate idea exchange and link our community together, the value of these is dependent upon you. Please take a minute to visit. To prevent that annoying spam, we ask that you register. Individual forums include: Conferences and MeetingsEducationEthicsFellowshipsInternshipsJob search questionsMedication Compliance and PersistenceMentoringPatient-reported OutcomesPost-Doc and Other TrainingRecommended ResourcesReimbursement and PricingResearch DesignRetrospective DatabasesSocial Media |
Jobs
|
Are you recruiting? Make sure your HR Dept. knows about the HealthEconomics.Com Employment Center. If your open position isn't posted here, you are missing a great opportunity to efficiently and cost-effectively recruit qualified candidates. To post a position, click here.
See who's recruiting! Jobs from US Oncology, Allergan, and Mapi!
Post a job for just $100/60 day posting or $450/5 jobs. Click here.
Director of Research, Workers Compensation Research Institute, Cambridge, Massachusetts
Manager, Health Outcomes, Allergen Inc., Irvine, CA
Director, Health Economics and Outcomes Research, PCS, Parsippany, New Jersey
Associate Outcomes Researcher, US Oncology, Spring, Texas
Director of Health Care Analytics, CVS Caremark, Greensboro, North Carolina
Director, Health Economics Outreach (HEOR), Abbott, Chicago, Illinois
Health Outcomes Research/Senior Research Analyst, HealthCore, Wilmington, Delaware
Director, Health Economics & Outcomes Research, i3 Innovus, Nationwide
Research Associate/Analyst, Global Health Economics & Pricing, Analytica International, New York
(Associate) Director - Market Access, Mapi Values, Adelphi Mill, Bollington, Macclesfield, Cheshire, UK
(Associate) Director - Market Access, Mapi Values, UK
Sr Manager, Health Economic, Outcomes and Value, Vertex Pharmaceuticals, Cambridge, Massachusetts
Group Director Real World Research and Programming, Bristol-Myers Squibb, New Jersey
Director of Marketing and Public Relations, The Stewart Group
Business Development / Programme Management Officer, Consultants for Health and Development (CHD) bv (international consulting group, specializing in public health and development)
Senior Health Economist, Double Helix Consulting, London or NY
Director, US Medical Affairs, Health Economics & Outcomes Research, Neuroscience and Virology, Bristol-Myers Squibb, Plainsboro, New Jersey
Director, US Medical Affairs, Health Economics & Outcomes Research, Immunoscience and Oncology, Bristol-Myers Squibb, Plainsboro, New Jersey
Research Scientist, Dossier Services, United BioSource Corporation, Bethesda, Maryland
Clinical Analytics- Senior Researcher, UnitedHealth Group - Irvine CA
ASSOCIATE DIRECTOR, VIROLOGY, Abbott, North Chicago, Illinois
Healthcare Modeling Scientist, Archimedes
Chair of Health Economics, The University Of Sheffield
Part Time Chair of Health Economics (0.5 FTE), The University Of Sheffield
Non-posted jobs (jobs we're aware of but are not on HealthEconomics.Com). The hyperlink is for further info.
Please let them know you saw this position in the HealthEconomics.Com Newsletter.
Joint Fellowship in Economics of Health, London. Closing date September 25th
Chair in Health Economics, University of Leicester, UK
Research Fellow in primary care, Bocconi University, Milan
Health Outcomes Advisor, West of London
DIRECTOR, MEDICAL AFFAIRS- NEUROLOGY/PAIN MANAGEMENT, mid size pharmaceutical company, New Jersey
Director of Health Outcomes/Pharmacoeconomics and Market Access, Mid-Atlantic US area.
Lead Health Economist, National Health Service, (Ref: GS109), AfC Band 8a, Glasgow
Med Econ Analyst for Health Plan, TEXAS
HEOR / Market Access Researchers to join a restructured
division of a multi-disciplinary consultancy located in the North West
of England. Contact Thomas Walton at 0121 616 3467.
Various Health economics/Outcomes research positions available throughout the US. Manager through Team Leader(VP). Contact Scott Kabo.
Director, Global Market Access, biotech, Maryland/Washington DC area.
Director, Health Economics and Outcomes Research, New Jersey
New Inquiry into Commissioning, UK
Health Economics PhD Studentship, Tenovus Cancer Research, Bangor University
Research Fellow in Economic Evaluation and Health Technology Assessment, York, UK
Research Assistant/Fellow, University of Aberdeen, Closing Date August 31, 2009
Senior Research Fellow/Research Fellow/Modelling/Operational Research, University of Southampton, UK
Director/International Health Economics Manager, UK
European Senior Project Manager, Market Access, Switzerland
European Director of Pricing and Reimbursement, UK
European Associate Director of Health Outcomes, Switzerland
Global Pricing and Market Access Knowledge Manager/Associate Director, Switzerland
European Associate Director/Senior Manager Health Economics, Belgium
Regional Pricing, Reimbursement and Market Access Manager, Belgium
Romanian Consultant, IMS Health
Director, Managed Markets Strategy
Pricing, Reimbursement, and Market Access Lead, Copenhagen
Director, Therapeutic Resource Centers (TRC), Medco Health Solutions, Inc.
Project Leader, Health Economics Modelling, i3 Innovus, Burlington, Ontario
Statistical/Economic Analyst, University of Pennsylvania School of Medicine, Philadelphia
Health Economist, Royal Tropical Institute, Cambodia, South East Asia
Health Economist, Synergus AB, Stockholm, Sweden
Professor and Director, HERG, Brunel University, London
Professor or Reader, HERG, Brunel University, London
Senior Health Outcomes Manager/International Project Leader, NHS Innovations, London
Vice President of Sales and Marketing, Pharmacy Benefit Management
Epidemiologist, Director, Chicago
Epidemiologist, Senior Manager, Chicago
Lecturer/Assistant Professor, Healthcare Management postgraduate program, University of Cyprus.
Principal Associate/Market Lead - Public Health and Epidemiology Practice, Abt Associates Domestic
Health Division, United States
Sr. Director, Health Economics and Outcomes Research with a PRO focus, Boston
Consultant - Health Economics & Outcomes Research, global leader providing market intelligence to the pharmaceutical and healthcare industries - ITALY
Senior Prinicipal Pricing & Reimbursement, IMS Health for New York office (remote location OK).
Head of Evidence Based Medicine - Paris
Project Manager of Evidence Based Medicine - Paris
DIRECTOR, HEALTH OUTCOMES & PHARMACO-ECONOMICS, Ref #3021, Mid-Atlantic US.
Senior Manager / Director Health Economics (reference HE3900), Innovative Biotech Co., South East England
Managed Care Clinical Pharmacy Manager (2 positions), Midwest for key MCO Pharmacy Clients.
Director Health Outcomes w/ Oncology focus, global pharma, Northern
New Jersey
Director, Pricing Reimbursement, global pharma company, London,UK
Field-based Associate Director of HEOR, Boehringer Ingelheim (one in Texas, one in Ridgefield, CT).
Director of HEOR (3 positions), global pharmaceutical company. Product launch opportunity.
Professorship in Economics/Econometrics of Health, University of Dundee, UK
Health Outcomes Program Leader, West of London
Fellowships in Health Economics and/or Medical Statistics, University of Bristol
Professor in Health Economics, Queen's University Belfast
5 Year Post-Doctoral Position in Health Economics, University of Adelaide, Australia
Lecturer in Medical Statistics or Health Economics, London School of Hygiene and Tropical Medicine
Director Health OutComes Pharmacoeconomics Communication, South Carolina
PhD Studentship in Health Economics, Bangor University, Wales
Overseas Lecturer in Health Economics and Policy, University of Nigeria, Enugu
Pricing & Reimbursement/Market Access Director, Belgium
Director Pricing & Reimbursement, London
Outcomes Research and Evidence Based Medicine Team Leader: Clinical Professionals, South East, UK
Health Services Researcher / Statistician: ABIM, Psychometrics Department, Philadelphia, Pennsylvania
Chair of Health Economics: University of Sheffield, School of Health and Related Research (ScHARR), Sheffield, UK
Part Time Chair of Health Economics (0.5 FTE): University of Sheffield, School of Health and Related Research (ScHARR), Sheffield, UK
Visiting Fellow in Health Economics: Berlin University of Technology, Berlin, Germany
Health Economist: National Institutes of Health, USA
Principal Manager, Health Economics and Outcomes Research (HEOR), Switzerland
Senior Health Economist/Social Policy Analyst: European Centre for Social Welfare Policy and Research, Vienna, Austria
Research Consultant, York Health Economics Consortium (YHEC), University of York
Lecturer/Health Economics- Dept. of Oral and Dental Science; University of Bristol
PhD Studentship, Peninsula Medical School, University of Exeter
Manager/Senior Manager/Principle Manager (Job ID 44318BR-Health, Economics & Outcomes Research (HE&OR), Novartis Pharmaceuticals
Senior Director - Health Care Relations (Requisition 1787606) , AstraZeneca, Wilmington, DE
Faculty Position, University of Houston, College of Pharmacy. Pharmacy Administration/Health Science Services Research
Department Head/Associate Professor/Professor, Auburn University - Harrison School of Pharmacy
HEOR Director, Midwest US
Director, Health Economics and Outcomes Research, Daiichi Sankyo, Inc., Parsippany, New Jersey
Director, Health Outcomes and Pharmacoeconomics Communications, Eisai
Head of Health Economics (Job ID: 00014124), Roche Products, UK
Lecturer/Associate Professor in Medicines Use, School of Pharmacy, University of Nottingham
Medical Director, industry, US.
Value Demonstration Leader - HEOR - AstraZeneca R&D Sweden.
Associate Director/Senior Manager Health Economics & Outcomes Research, Global role, UK
Associate Director/Director Outcomes Research Oncology - Pfizer NYC
Health Economist / Economic Modeller (Ref #: 3169-9-M), School of Medicine - the Wessex Institute
Sr. Consultant (modelling focus), HEOR, Market Access & Pricing Reimbursement, International Consulting Group, Germany and Belgium
PhD in health economics - Centre for Health Economics at Monash University, Australia.
Research Fellows, School of Medicine and Dentistry, Health Economics Research Unit, University of Aberdeen, King's College, Aberdeen,
Reference number:YHE063R
PhD Studentship in Health Economics, UNIVERSITY OF GLAMORGAN
Health Economics and Outcomes Research Manager, AXESS Ltd, Richmond upon
Thames, Surrey
Senior Researcher - diabetes modelling, University of Oxford
Health Economist (Research Fellow), School of Medicine, Department of Health Sciences, University of Leicester
Have an open position? Want to gain global exposure with >5,300 professionals for your open jobs? Click here to post your position today. It takes just 5 minutes!
|
| Upcoming Conferences |
Contact us to promote your conference in this newsletter. For a list of all conferences, click here.
Advertise your conferences here!
August 17-19, 2009: Measurement, Design, and Analysis Methods, Harvard School of Public Health, Boston, MA
August 24-25, 2009: The 3rd Annual Latin America Clinical Trials Conference, Sao Paulo, Brazil
August 25, 2009: Complimentary Webinar: Comparative Effectiveness: Where are We and Where are We Going?
August 25-27, 2009: Health Economics from Theory to Practice: 3 day course, St. Hilda's College, Oxford, UK
August 26-28, 2009: Institute of Pharmaceutical Management's Courses on Managed Care/Payers, Princeton,
New Jersey
August 31, 2009: Call for Abstracts: ISPOR South Africa 2nd Annual Conference. Closing date for Submission.
September 1, 2009: CBI's 3-Part Webinar Series on Pricing; Part I: What Pricing Techniques are Appropriate?
Sept. 2-6, 2009: EIGHTEENTH EUROPEAN WORKSHOP ON ECONOMETRICS AND HEALTH ECONOMICS, Cagliari, Sardinia
Sept. 10-12, 2009, ISPOR 2nd Latin American Conf., Rio de Janeiro
Sept. 16-17, 2009: Formulary and Reimbursement Strategies for Effective Product Planning, Philadelphia, PA
September 16, 2009: Building on PROMs: putting health outcomes at the heart of NHS decision making, London
September 21-23, 2009: ISPOR South Africa 2nd Annual Conference, North West University, Potchefstroom
September 22 - 23, 2009: Executive Forum on Public-Private Purchaser Partnerships, Atlanta, GA
September 23-24, 2009: WinBUGS in Health Economic Evaluations, Cambridge
Sept. 24-25, 2009: Market & Patient Access for Chronic Disease Therapies, Vienna, Austria
September 24-25, 2009: CBI's Product Launch Series: 2nd Annual West Coast Summit on Medical Device and Bio/Pharmaceutical Commercialization and Product Launches, San Francisco, CA
September 28, 2009: DIA Biosimilars Workshop, London, UK
September 28-29, 2009: MEPS and HCUP Data Users Workshop, Rockville, MD
September 30, 2009: CBI's 3-Part Webinar Series on Pricing; Part II: Segmentation: The Why and How?
September 30- October 3, 2009: 12th European Health Forum Gastein: Financial Crisis and Health Policy, Bad Hofgastein
October 1-2, 2009: 31st Australian Conference for Health Economists, Hobart, Australia
October 2, 2009: YHEC Training Event: "Early Modelling": Using Models to Inform Drug and Device Development, University of York
October 2-3, 2009: Annual Health Econometrics Workshop, Chicago
October 5-6, 2009: CBI's 4th Annual Effective Oncology Benefit Management, Chicago, IL
October 6, 2009: Webinar: Introduction to Health Outcomes for Pharma, Biotech and Medical Device, 1:30-3:30 EST
October 6-7, 2009: Pharmacertical & Medical Device Risk-Sharing & Value-Based Pricing & Reimbursement Schemes, Boston, MA
October 8-10, 2009: Portugese Health Economics Association 11th Annual Health Economics Conference, Porto, Portugal
October 12-14, 2009: Workshop: An Introduction to Measuring Efficiency in Public Sector, University of York, UK
October 15, 2009: Workshop: Toward a Global Perspective on the Economics of Treating and Preventing Diabetes, Harvard University, Boston
October 15-16, 2009: The 2009 Value Driven Pharma Conference: Maximize Market Share in an Era of Value-Based Benefit Design, Washington DC
Oct. 18-21, 2009: 31st Annual Meeting of the Society for Medical Decision Making, Hollywood, CA
October 21, 2009: CBI's 3-Part Webinar Series on Pricing: Part III: Global Pricing Issues- An Overview
Oct. 23-24, 2009: 7th Annual Southeastern Health Economics Study Group Conference, Atlanta, GA
Oct. 24-27, 2009, ISPOR 12th Annual European Conf., Paris
Oct. 29-31, 2009: Nordic Econometric Meeting, Lund, Sweden
November 1-4, 2009: Guidelines International Network (GIN) Conference, Lisbon, Portugal
November 12-13, 2009: Fall Managed Care Forum, Bellagio, Las Vegas, NV
November 17-18, 2009: 3rd CBI Forum Evidence-Based Medicine and Comparative Effectiveness Research for the Bio/Pharma and Med Device Industries, Philadelphia, PA
November 17-18, 2009: 5th CBI Forum: Patient Reported Outcomes, Philadelphia, PA
November 25-26, 2009: DIA Health Technology Assessment Forum, Paris
November 27, 2009: Understanding and Critiquing Health Economic Models, University of York
November 30, 2009: Identifying Diagnostic Test Accuracy Studies: Challenges and Strategies, University of York
Dec. 7-9, 2009: Adv. Methods of Cost-Effectiveness Analysis, Univ. Oxford
Dec. 8-11, 2009: Health Technology Assessment World, London, UK
December 8-9, 2009: CBI's Product Launch Series: 8th Annual Commercialization Strategies for Pharmaceutical Product Launches, Philadelphia, PA
January 10-16, 2010: Global Health Leadership Forum, Berkeley, California
February 2 - 4, 2010: Employer Health & Human Capital Congress, Washington, DC
April 7-9, 2010: First Australian Workshop on Econometrics and Health Economics, Melbourne, Australia
|
SPONSORSHIP OPPORTUNITIES
|
Reach more than 5,300 HEOR executives. The HealthEconomics.Com Newsletter and website has limited sponsorship and
advertising opportunities available. Reserve your space today. For more
information please contact newsletter@healtheconomics.com or visit HealthEconomics.Com. |
|
|
|
|
|
Spotlight Feature
A paid advertising feature
|
|
MedMining licenses custom,
de-identified Electronic Health Record (EHR)-based data extracts that deliver
unique insights into pharmacoeconomics and health outcomes research based on
care provided at Geisinger Health System*.
MedMining's data reflect patients
histories across the care continuum (inpatient, outpatient, primary, specialty
care), regardless of payor (Commercial, Medicare, Medicaid,
Cash-Paying).
MedMining's clinical data are uniquely deep, including
vital signs, a 1,110+ distinct lab test menu yielding 22.5 million results
annually, lifestyle data (smoking/employment status), day of death, medications
(sig codes, etc.), ICD-9 codes, CPT-4/HCPCS codes, flowsheet data, demographics,
and much more. Speciality (Cancer Registry, DXA, PFT, etc.) and manual chart
review data also available.
MedMining's economic data represents the
actual cost of treatment from the provider's perspective. Proprietary algorithms
consider fixed, variable, direct, and indirect costs. Actual cost data
available at the encounter, physician, hospital, procedure, and medication
level. Charge and reimbursement data also available.
Along with
clinical and economic data, MedMining can link claims data for Geisinger
patients who also carry Geisinger's Health Plan (GHP).
*750+ physicians,
multiple hospital campuses, 75 medical and surgical subspecialties, 40
ambulatory community practice sites, 220,000 member health plan, 3 research
centers, and a commercially-focused ventures and innovation group.
For more information, click the links below:
Visit MedMining today.
|
HealthEconomics.Com
Sponsors
|
Become A Sponsor
|
|
|